Global Multiple Sclerosis Therapeutics Market Insights, Forecast to 2028

TABLE OF CONTENTS

1 Report Business Overview

• 1.1 Study Scope
• 1.2 Market Analysis by Type
  • 1.2.1 Global Multiple Sclerosis Therapeutics Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
  • 1.2.2 Beta Interferon
  • 1.2.3 Corticosteroids
  • 1.2.4 Monoclonal Antibodies
  • 1.2.5 Antineoplastic Agents
  • 1.2.6 Others
• 1.3 Market by Distribution Channel
  • 1.3.1 Global Multiple Sclerosis Therapeutics Market Size Growth Rate by Distribution Channel, 2017 VS 2021 VS 2028
  • 1.3.2 Hospital Pharmacies
  • 1.3.3 Retail Pharmacies
  • 1.3.4 e-Commerce
• 1.4 Study Objectives
• 1.5 Years Considered

2 Global Growth Trends

• 2.1 Global Multiple Sclerosis Therapeutics Market Perspective (2017-2028)
• 2.2 Multiple Sclerosis Therapeutics Growth Trends by Region
  • 2.2.1 Multiple Sclerosis Therapeutics Market Size by Region: 2017 VS 2021 VS 2028
  • 2.2.2 Multiple Sclerosis Therapeutics Historic Market Size by Region (2017-2022)
  • 2.2.3 Multiple Sclerosis Therapeutics Forecasted Market Size by Region (2023-2028)
• 2.3 Multiple Sclerosis Therapeutics Market Dynamics
  • 2.3.1 Multiple Sclerosis Therapeutics Industry Trends
  • 2.3.2 Multiple Sclerosis Therapeutics Market Drivers
  • 2.3.3 Multiple Sclerosis Therapeutics Market Challenges
  • 2.3.4 Multiple Sclerosis Therapeutics Market Restraints

3 Competition Landscape by Key Players

• 3.1 Global Top Multiple Sclerosis Therapeutics Players by Revenue
  • 3.1.1 Global Top Multiple Sclerosis Therapeutics Players by Revenue (2017-2022)
  • 3.1.2 Global Multiple Sclerosis Therapeutics Revenue Market Share by Players (2017-2022)
• 3.2 Global Multiple Sclerosis Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
• 3.3 Players Covered: Ranking by Multiple Sclerosis Therapeutics Revenue
• 3.4 Global Multiple Sclerosis Therapeutics Market Concentration Ratio
  • 3.4.1 Global Multiple Sclerosis Therapeutics Market Concentration Ratio (CR5 and HHI)
  • 3.4.2 Global Top 10 and Top 5 Companies by Multiple Sclerosis Therapeutics Revenue in 2021
• 3.5 Multiple Sclerosis Therapeutics Key Players Head office and Area Served
• 3.6 Key Players Multiple Sclerosis Therapeutics Product Solution and Service
• 3.7 Date of Enter into Multiple Sclerosis Therapeutics Market
• 3.8 Mergers & Acquisitions, Expansion Plans

4 Multiple Sclerosis Therapeutics Breakdown Data by Type

• 4.1 Global Multiple Sclerosis Therapeutics Historic Market Size by Type (2017-2022)
• 4.2 Global Multiple Sclerosis Therapeutics Forecasted Market Size by Type (2023-2028)

5 Multiple Sclerosis Therapeutics Breakdown Data by Distribution Channel

• 5.1 Global Multiple Sclerosis Therapeutics Historic Market Size by Distribution Channel (2017-2022)
• 5.2 Global Multiple Sclerosis Therapeutics Forecasted Market Size by Distribution Channel (2023-2028)

6 North America

• 6.1 North America Multiple Sclerosis Therapeutics Market Size (2017-2028)
• 6.2 North America Multiple Sclerosis Therapeutics Market Size by Type
  • 6.2.1 North America Multiple Sclerosis Therapeutics Market Size by Type (2017-2022)
  • 6.2.2 North America Multiple Sclerosis Therapeutics Market Size by Type (2023-2028)
  • 6.2.3 North America Multiple Sclerosis Therapeutics Market Share by Type (2017-2028)
• 6.3 North America Multiple Sclerosis Therapeutics Market Size by Distribution Channel
  • 6.3.1 North America Multiple Sclerosis Therapeutics Market Size by Distribution Channel (2017-2022)
  • 6.3.2 North America Multiple Sclerosis Therapeutics Market Size by Distribution Channel (2023-2028)
  • 6.3.3 North America Multiple Sclerosis Therapeutics Market Share by Distribution Channel (2017-2028)
• 6.4 North America Multiple Sclerosis Therapeutics Market Size by Country
  • 6.4.1 North America Multiple Sclerosis Therapeutics Market Size by Country (2017-2022)
  • 6.4.2 North America Multiple Sclerosis Therapeutics Market Size by Country (2023-2028)
  • 6.4.3 U.S.
  • 6.4.4 Canada

7 Europe

• 7.1 Europe Multiple Sclerosis Therapeutics Market Size (2017-2028)
• 7.2 Europe Multiple Sclerosis Therapeutics Market Size by Type
  • 7.2.1 Europe Multiple Sclerosis Therapeutics Market Size by Type (2017-2022)
  • 7.2.2 Europe Multiple Sclerosis Therapeutics Market Size by Type (2023-2028)
  • 7.2.3 Europe Multiple Sclerosis Therapeutics Market Share by Type (2017-2028)
• 7.3 Europe Multiple Sclerosis Therapeutics Market Size by Distribution Channel
  • 7.3.1 Europe Multiple Sclerosis Therapeutics Market Size by Distribution Channel (2017-2022)
  • 7.3.2 Europe Multiple Sclerosis Therapeutics Market Size by Distribution Channel (2023-2028)
  • 7.3.3 Europe Multiple Sclerosis Therapeutics Market Share by Distribution Channel (2017-2028)
• 7.4 Europe Multiple Sclerosis Therapeutics Market Size by Country
  • 7.4.1 Europe Multiple Sclerosis Therapeutics Market Size by Country (2017-2022)
  • 7.4.2 Europe Multiple Sclerosis Therapeutics Market Size by Country (2023-2028)
  • 7.4.3 Germany
  • 7.4.4 France
  • 7.4.5 U.K.
  • 7.4.6 Italy
  • 7.4.7 Russia
  • 7.4.8 Nordic Countries

8 Asia-Pacific

• 8.1 Asia-Pacific Multiple Sclerosis Therapeutics Market Size (2017-2028)
• 8.2 Asia-Pacific Multiple Sclerosis Therapeutics Market Size by Type
  • 8.2.1 Asia-Pacific Multiple Sclerosis Therapeutics Market Size by Type (2017-2022)
  • 8.2.2 Asia-Pacific Multiple Sclerosis Therapeutics Market Size by Type (2023-2028)
  • 8.2.3 Asia-Pacific Multiple Sclerosis Therapeutics Market Share by Type (2017-2028)
• 8.3 Asia-Pacific Multiple Sclerosis Therapeutics Market Size by Distribution Channel
  • 8.3.1 Asia-Pacific Multiple Sclerosis Therapeutics Market Size by Distribution Channel (2017-2022)
  • 8.3.2 Asia-Pacific Multiple Sclerosis Therapeutics Market Size by Distribution Channel (2023-2028)
  • 8.3.3 Asia-Pacific Multiple Sclerosis Therapeutics Market Share by Distribution Channel (2017-2028)
• 8.4 Asia-Pacific Multiple Sclerosis Therapeutics Market Size by Region
  • 8.4.1 Asia-Pacific Multiple Sclerosis Therapeutics Market Size by Region (2017-2022)
  • 8.4.2 Asia-Pacific Multiple Sclerosis Therapeutics Market Size by Region (2023-2028)
  • 8.4.3 China
  • 8.4.4 Japan
  • 8.4.5 South Korea
  • 8.4.6 Southeast Asia
  • 8.4.7 India
  • 8.4.8 Australia

9 Latin America

• 9.1 Latin America Multiple Sclerosis Therapeutics Market Size (2017-2028)
• 9.2 Latin America Multiple Sclerosis Therapeutics Market Size by Type
  • 9.2.1 Latin America Multiple Sclerosis Therapeutics Market Size by Type (2017-2022)
  • 9.2.2 Latin America Multiple Sclerosis Therapeutics Market Size by Type (2023-2028)
  • 9.2.3 Latin America Multiple Sclerosis Therapeutics Market Share by Type (2017-2028)
• 9.3 Latin America Multiple Sclerosis Therapeutics Market Size by Distribution Channel
  • 9.3.1 Latin America Multiple Sclerosis Therapeutics Market Size by Distribution Channel (2017-2022)
  • 9.3.2 Latin America Multiple Sclerosis Therapeutics Market Size by Distribution Channel (2023-2028)
  • 9.3.3 Latin America Multiple Sclerosis Therapeutics Market Share by Distribution Channel (2017-2028)
• 9.4 Latin America Multiple Sclerosis Therapeutics Market Size by Country
  • 9.4.1 Latin America Multiple Sclerosis Therapeutics Market Size by Country (2017-2022)
  • 9.4.2 Latin America Multiple Sclerosis Therapeutics Market Size by Country (2023-2028)
  • 9.4.3 Mexico
  • 9.4.4 Brazil

10 Middle East & Africa

• 10.1 Middle East & Africa Multiple Sclerosis Therapeutics Market Size (2017-2028)
• 10.2 Middle East & Africa Multiple Sclerosis Therapeutics Market Size by Type
  • 10.2.1 Middle East & Africa Multiple Sclerosis Therapeutics Market Size by Type (2017-2022)
  • 10.2.2 Middle East & Africa Multiple Sclerosis Therapeutics Market Size by Type (2023-2028)
  • 10.2.3 Middle East & Africa Multiple Sclerosis Therapeutics Market Share by Type (2017-2028)
• 10.3 Middle East & Africa Multiple Sclerosis Therapeutics Market Size by Distribution Channel
  • 10.3.1 Middle East & Africa Multiple Sclerosis Therapeutics Market Size by Distribution Channel (2017-2022)
  • 10.3.2 Middle East & Africa Multiple Sclerosis Therapeutics Market Size by Distribution Channel (2023-2028)
  • 10.3.3 Middle East & Africa Multiple Sclerosis Therapeutics Market Share by Distribution Channel (2017-2028)
• 10.4 Middle East & Africa Multiple Sclerosis Therapeutics Market Size by Country
  • 10.4.1 Middle East & Africa Multiple Sclerosis Therapeutics Market Size by Country (2017-2022)
  • 10.4.2 Middle East & Africa Multiple Sclerosis Therapeutics Market Size by Country (2023-2028)
  • 10.4.3 Turkey
  • 10.4.4 Saudi Arabia
  • 10.4.5 UAE

11 Key Players Profiles

• 11.1 Novartis
  • 11.1.1 Novartis Company Details
  • 11.1.2 Novartis Business Overview
  • 11.1.3 Novartis Multiple Sclerosis Therapeutics Introduction
  • 11.1.4 Novartis Revenue in Multiple Sclerosis Therapeutics Business (2017-2022)
  • 11.1.5 Novartis Recent Developments
• 11.2 Teva Pharmaceuticals
  • 11.2.1 Teva Pharmaceuticals Company Details
  • 11.2.2 Teva Pharmaceuticals Business Overview
  • 11.2.3 Teva Pharmaceuticals Multiple Sclerosis Therapeutics Introduction
  • 11.2.4 Teva Pharmaceuticals Revenue in Multiple Sclerosis Therapeutics Business (2017-2022)
  • 11.2.5 Teva Pharmaceuticals Recent Developments
• 11.3 Sanofi Genzyme
  • 11.3.1 Sanofi Genzyme Company Details
  • 11.3.2 Sanofi Genzyme Business Overview
  • 11.3.3 Sanofi Genzyme Multiple Sclerosis Therapeutics Introduction
  • 11.3.4 Sanofi Genzyme Revenue in Multiple Sclerosis Therapeutics Business (2017-2022)
  • 11.3.5 Sanofi Genzyme Recent Developments
• 11.4 Bayer
  • 11.4.1 Bayer Company Details
  • 11.4.2 Bayer Business Overview
  • 11.4.3 Bayer Multiple Sclerosis Therapeutics Introduction
  • 11.4.4 Bayer Revenue in Multiple Sclerosis Therapeutics Business (2017-2022)
  • 11.4.5 Bayer Recent Developments
• 11.5 Pfizer
  • 11.5.1 Pfizer Company Details
  • 11.5.2 Pfizer Business Overview
  • 11.5.3 Pfizer Multiple Sclerosis Therapeutics Introduction
  • 11.5.4 Pfizer Revenue in Multiple Sclerosis Therapeutics Business (2017-2022)
  • 11.5.5 Pfizer Recent Developments
• 11.6 Biogen Idec
  • 11.6.1 Biogen Idec Company Details
  • 11.6.2 Biogen Idec Business Overview
  • 11.6.3 Biogen Idec Multiple Sclerosis Therapeutics Introduction
  • 11.6.4 Biogen Idec Revenue in Multiple Sclerosis Therapeutics Business (2017-2022)
  • 11.6.5 Biogen Idec Recent Developments
• 11.7 Merck
  • 11.7.1 Merck Company Details
  • 11.7.2 Merck Business Overview
  • 11.7.3 Merck Multiple Sclerosis Therapeutics Introduction
  • 11.7.4 Merck Revenue in Multiple Sclerosis Therapeutics Business (2017-2022)
  • 11.7.5 Merck Recent Developments
• 11.8 AbbVie
  • 11.8.1 AbbVie Company Details
  • 11.8.2 AbbVie Business Overview
  • 11.8.3 AbbVie Multiple Sclerosis Therapeutics Introduction
  • 11.8.4 AbbVie Revenue in Multiple Sclerosis Therapeutics Business (2017-2022)
  • 11.8.5 AbbVie Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

• 13.1 Research Methodology
  • 13.1.1 Methodology/Research Approach
  • 13.1.2 Data Source
• 13.2 Author Details
• 13.3 Disclaimer

• Table 1. Global Multiple Sclerosis Therapeutics Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
• Table 2. Key Players of Beta Interferon
• Table 3. Key Players of Corticosteroids
• Table 4. Key Players of Monoclonal Antibodies
• Table 5. Key Players of Antineoplastic Agents
• Table 6. Key Players of Others
• Table 7. Global Multiple Sclerosis Therapeutics Market Size Growth Rate by Distribution Channel (US$ Million), 2017 VS 2021 VS 2028
• Table 8. Global Multiple Sclerosis Therapeutics Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
• Table 9. Global Multiple Sclerosis Therapeutics Market Size by Region (2017-2022) & (US$ Million)
• Table 10. Global Multiple Sclerosis Therapeutics Market Share by Region (2017-2022)
• Table 11. Global Multiple Sclerosis Therapeutics Forecasted Market Size by Region (2023-2028) & (US$ Million)
• Table 12. Global Multiple Sclerosis Therapeutics Market Share by Region (2023-2028)
• Table 13. Multiple Sclerosis Therapeutics Market Trends
• Table 14. Multiple Sclerosis Therapeutics Market Drivers
• Table 15. Multiple Sclerosis Therapeutics Market Challenges
• Table 16. Multiple Sclerosis Therapeutics Market Restraints
• Table 17. Global Multiple Sclerosis Therapeutics Revenue by Players (2017-2022) & (US$ Million)
• Table 18. Global Multiple Sclerosis Therapeutics Revenue Share by Players (2017-2022)
• Table 19. Global Top Multiple Sclerosis Therapeutics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Multiple Sclerosis Therapeutics as of 2021)
• Table 20. Ranking of Global Top Multiple Sclerosis Therapeutics Companies by Revenue (US$ Million) in 2021
• Table 21. Global 5 Largest Players Market Share by Multiple Sclerosis Therapeutics Revenue (CR5 and HHI) & (2017-2022)
• Table 22. Key Players Headquarters and Area Served
• Table 23. Key Players Multiple Sclerosis Therapeutics Product Solution and Service
• Table 24. Date of Enter into Multiple Sclerosis Therapeutics Market
• Table 25. Mergers & Acquisitions, Expansion Plans
• Table 26. Global Multiple Sclerosis Therapeutics Market Size by Type (2017-2022) & (US$ Million)
• Table 27. Global Multiple Sclerosis Therapeutics Revenue Market Share by Type (2017-2022)
• Table 28. Global Multiple Sclerosis Therapeutics Forecasted Market Size by Type (2023-2028) & (US$ Million)
• Table 29. Global Multiple Sclerosis Therapeutics Revenue Market Share by Type (2023-2028)
• Table 30. Global Multiple Sclerosis Therapeutics Market Size by Distribution Channel (2017-2022) & (US$ Million)
• Table 31. Global Multiple Sclerosis Therapeutics Revenue Share by Distribution Channel (2017-2022)
• Table 32. Global Multiple Sclerosis Therapeutics Forecasted Market Size by Distribution Channel (2023-2028) & (US$ Million)
• Table 33. Global Multiple Sclerosis Therapeutics Revenue Share by Distribution Channel (2023-2028)
• Table 34. North America Multiple Sclerosis Therapeutics Market Size by Type (2017-2022) & (US$ Million)
• Table 35. North America Multiple Sclerosis Therapeutics Market Size by Type (2023-2028) & (US$ Million)
• Table 36. North America Multiple Sclerosis Therapeutics Market Size by Distribution Channel (2017-2022) & (US$ Million)
• Table 37. North America Multiple Sclerosis Therapeutics Market Size by Distribution Channel (2023-2028) & (US$ Million)
• Table 38. North America Multiple Sclerosis Therapeutics Market Size by Country (2017-2022) & (US$ Million)
• Table 39. North America Multiple Sclerosis Therapeutics Market Size by Country (2023-2028) & (US$ Million)
• Table 40. Europe Multiple Sclerosis Therapeutics Market Size by Type (2017-2022) & (US$ Million)
• Table 41. Europe Multiple Sclerosis Therapeutics Market Size by Type (2023-2028) & (US$ Million)
• Table 42. Europe Multiple Sclerosis Therapeutics Market Size by Distribution Channel (2017-2022) & (US$ Million)
• Table 43. Europe Multiple Sclerosis Therapeutics Market Size by Distribution Channel (2023-2028) & (US$ Million)
• Table 44. Europe Multiple Sclerosis Therapeutics Market Size by Country (2017-2022) & (US$ Million)
• Table 45. Europe Multiple Sclerosis Therapeutics Market Size by Country (2023-2028) & (US$ Million)
• Table 46. Asia Pacific Multiple Sclerosis Therapeutics Market Size by Type (2017-2022) & (US$ Million)
• Table 47. Asia Pacific Multiple Sclerosis Therapeutics Market Size by Type (2023-2028) & (US$ Million)
• Table 48. Asia Pacific Multiple Sclerosis Therapeutics Market Size by Distribution Channel (2017-2022) & (US$ Million)
• Table 49. Asia Pacific Multiple Sclerosis Therapeutics Market Size by Distribution Channel (2023-2028) & (US$ Million)
• Table 50. Asia Pacific Multiple Sclerosis Therapeutics Market Size by Region (2017-2022) & (US$ Million)
• Table 51. Asia Pacific Multiple Sclerosis Therapeutics Market Size by Region (2023-2028) & (US$ Million)
• Table 52. Latin America Multiple Sclerosis Therapeutics Market Size by Type (2017-2022) & (US$ Million)
• Table 53. Latin America Multiple Sclerosis Therapeutics Market Size by Type (2023-2028) & (US$ Million)
• Table 54. Latin America Multiple Sclerosis Therapeutics Market Size by Distribution Channel (2017-2022) & (US$ Million)
• Table 55. Latin America Multiple Sclerosis Therapeutics Market Size by Distribution Channel (2023-2028) & (US$ Million)
• Table 56. Latin America Multiple Sclerosis Therapeutics Market Size by Country (2017-2022) & (US$ Million)
• Table 57. Latin America Multiple Sclerosis Therapeutics Market Size by Country (2023-2028) & (US$ Million)
• Table 58. Middle East and Africa Multiple Sclerosis Therapeutics Market Size by Type (2017-2022) & (US$ Million)
• Table 59. Middle East and Africa Multiple Sclerosis Therapeutics Market Size by Type (2023-2028) & (US$ Million)
• Table 60. Middle East and Africa Multiple Sclerosis Therapeutics Market Size by Distribution Channel (2017-2022) & (US$ Million)
• Table 61. Middle East and Africa Multiple Sclerosis Therapeutics Market Size by Distribution Channel (2023-2028) & (US$ Million)
• Table 62. Middle East and Africa Multiple Sclerosis Therapeutics Market Size by Country (2017-2022) & (US$ Million)
• Table 63. Middle East and Africa Multiple Sclerosis Therapeutics Market Size by Country (2023-2028) & (US$ Million)
• Table 64. Novartis Company Details
• Table 65. Novartis Business Overview
• Table 66. Novartis Multiple Sclerosis Therapeutics Product
• Table 67. Novartis Revenue in Multiple Sclerosis Therapeutics Business (2017-2022) & (US$ Million)
• Table 68. Novartis Recent Developments
• Table 69. Teva Pharmaceuticals Company Details
• Table 70. Teva Pharmaceuticals Business Overview
• Table 71. Teva Pharmaceuticals Multiple Sclerosis Therapeutics Product
• Table 72. Teva Pharmaceuticals Revenue in Multiple Sclerosis Therapeutics Business (2017-2022) & (US$ Million)
• Table 73. Teva Pharmaceuticals Recent Developments
• Table 74. Sanofi Genzyme Company Details
• Table 75. Sanofi Genzyme Business Overview
• Table 76. Sanofi Genzyme Multiple Sclerosis Therapeutics Product
• Table 77. Sanofi Genzyme Revenue in Multiple Sclerosis Therapeutics Business (2017-2022) & (US$ Million)
• Table 78. Sanofi Genzyme Recent Developments
• Table 79. Bayer Company Details
• Table 80. Bayer Business Overview
• Table 81. Bayer Multiple Sclerosis Therapeutics Product
• Table 82. Bayer Revenue in Multiple Sclerosis Therapeutics Business (2017-2022) & (US$ Million)
• Table 83. Bayer Recent Developments
• Table 84. Pfizer Company Details
• Table 85. Pfizer Business Overview
• Table 86. Pfizer Multiple Sclerosis Therapeutics Product
• Table 87. Pfizer Revenue in Multiple Sclerosis Therapeutics Business (2017-2022) & (US$ Million)
• Table 88. Pfizer Recent Developments
• Table 89. Biogen Idec Company Details
• Table 90. Biogen Idec Business Overview
• Table 91. Biogen Idec Multiple Sclerosis Therapeutics Product
• Table 92. Biogen Idec Revenue in Multiple Sclerosis Therapeutics Business (2017-2022) & (US$ Million)
• Table 93. Biogen Idec Recent Developments
• Table 94. Merck Company Details
• Table 95. Merck Business Overview
• Table 96. Merck Multiple Sclerosis Therapeutics Product
• Table 97. Merck Revenue in Multiple Sclerosis Therapeutics Business (2017-2022) & (US$ Million)
• Table 98. Merck Recent Developments
• Table 99. AbbVie Company Details
• Table 100. AbbVie Business Overview
• Table 101. AbbVie Multiple Sclerosis Therapeutics Product
• Table 102. AbbVie Revenue in Multiple Sclerosis Therapeutics Business (2017-2022) & (US$ Million)
• Table 103. AbbVie Recent Developments
• Table 104. Research Programs/Design for This Report
• Table 105. Key Data Information from Secondary Sources
• Table 106. Key Data Information from Primary Sources

List of Figures

• Figure 1. Global Multiple Sclerosis Therapeutics Market Share by Type: 2021 VS 2028
• Figure 2. Beta Interferon Features
• Figure 3. Corticosteroids Features
• Figure 4. Monoclonal Antibodies Features
• Figure 5. Antineoplastic Agents Features
• Figure 6. Others Features
• Figure 7. Global Multiple Sclerosis Therapeutics Market Share by Distribution Channel: 2021 VS 2028
• Figure 8. Hospital Pharmacies Case Studies
• Figure 9. Retail Pharmacies Case Studies
• Figure 10. e-Commerce Case Studies
• Figure 11. Multiple Sclerosis Therapeutics Report Years Considered
• Figure 12. Global Multiple Sclerosis Therapeutics Market Size (US$ Million), Year-over-Year: 2017-2028
• Figure 13. Global Multiple Sclerosis Therapeutics Market Size, (US$ Million), 2017 VS 2021 VS 2028
• Figure 14. Global Multiple Sclerosis Therapeutics Market Share by Region: 2021 VS 2028
• Figure 15. Global Multiple Sclerosis Therapeutics Market Share by Players in 2021
• Figure 16. Global Top Multiple Sclerosis Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Multiple Sclerosis Therapeutics as of 2021)
• Figure 17. The Top 10 and 5 Players Market Share by Multiple Sclerosis Therapeutics Revenue in 2021
• Figure 18. North America Multiple Sclerosis Therapeutics Market Size YoY (2017-2028) & (US$ Million)
• Figure 19. North America Multiple Sclerosis Therapeutics Market Size Market Share by Type (2017-2028)
• Figure 20. North America Multiple Sclerosis Therapeutics Market Size Market Share by Distribution Channel (2017-2028)
• Figure 21. North America Multiple Sclerosis Therapeutics Market Size Share by Country (2017-2028)
• Figure 22. United States Multiple Sclerosis Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 23. Canada Multiple Sclerosis Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 24. Europe Multiple Sclerosis Therapeutics Market Size YoY (2017-2028) & (US$ Million)
• Figure 25. Europe Multiple Sclerosis Therapeutics Market Size Market Share by Type (2017-2028)
• Figure 26. Europe Multiple Sclerosis Therapeutics Market Size Market Share by Distribution Channel (2017-2028)
• Figure 27. Europe Multiple Sclerosis Therapeutics Market Size Share by Country (2017-2028)
• Figure 28. Germany Multiple Sclerosis Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 29. France Multiple Sclerosis Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 30. U.K. Multiple Sclerosis Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 31. Italy Multiple Sclerosis Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 32. Russia Multiple Sclerosis Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 33. Nordic Countries Multiple Sclerosis Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 34. Asia-Pacific Multiple Sclerosis Therapeutics Market Size YoY (2017-2028) & (US$ Million)
• Figure 35. Asia Pacific Multiple Sclerosis Therapeutics Market Size Market Share by Type (2017-2028)
• Figure 36. Asia Pacific Multiple Sclerosis Therapeutics Market Size Market Share by Distribution Channel (2017-2028)
• Figure 37. Asia Pacific Multiple Sclerosis Therapeutics Market Size Share by Region (2017-2028)
• Figure 38. China Multiple Sclerosis Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 39. Japan Multiple Sclerosis Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 40. South Korea Multiple Sclerosis Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 41. Southeast Asia Multiple Sclerosis Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 42. India Multiple Sclerosis Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 43. Australia Multiple Sclerosis Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)

List of Figures

• Figure 44. Latin America Multiple Sclerosis Therapeutics Market Size YoY (2017-2028) & (US$ Million)
• Figure 45. Latin America Multiple Sclerosis Therapeutics Market Size Market Share by Type (2017-2028)
• Figure 46. Latin America Multiple Sclerosis Therapeutics Market Size Market Share by Distribution Channel (2017-2028)
• Figure 47. Latin America Multiple Sclerosis Therapeutics Market Size Share by Country (2017-2028)
• Figure 48. Mexico Multiple Sclerosis Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 49. Brazil Multiple Sclerosis Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 50. Middle East & Africa Multiple Sclerosis Therapeutics Market Size YoY (2017-2028) & (US$ Million)
• Figure 51. Middle East and Africa Multiple Sclerosis Therapeutics Market Size Market Share by Type (2017-2028)
• Figure 52. Middle East and Africa Multiple Sclerosis Therapeutics Market Size Market Share by Distribution Channel (2017-2028)
• Figure 53. Middle East and Africa Multiple Sclerosis Therapeutics Market Size Share by Country (2017-2028)
• Figure 54. Turkey Multiple Sclerosis Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 55. Saudi Arabia Multiple Sclerosis Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 56. UAE Multiple Sclerosis Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 57. Novartis Revenue Growth Rate in Multiple Sclerosis Therapeutics Business (2017-2022)
• Figure 58. Teva Pharmaceuticals Revenue Growth Rate in Multiple Sclerosis Therapeutics Business (2017-2022)
• Figure 59. Sanofi Genzyme Revenue Growth Rate in Multiple Sclerosis Therapeutics Business (2017-2022)
• Figure 60. Bayer Revenue Growth Rate in Multiple Sclerosis Therapeutics Business (2017-2022)
• Figure 61. Pfizer Revenue Growth Rate in Multiple Sclerosis Therapeutics Business (2017-2022)
• Figure 62. Biogen Idec Revenue Growth Rate in Multiple Sclerosis Therapeutics Business (2017-2022)
• Figure 63. Merck Revenue Growth Rate in Multiple Sclerosis Therapeutics Business (2017-2022)
• Figure 64. AbbVie Revenue Growth Rate in Multiple Sclerosis Therapeutics Business (2017-2022)
• Figure 65. Bottom-up and Top-down Approaches for This Report
• Figure 66. Data Triangulation
• Figure 67. Key Executives Interviewed